From the substrate candidates, we focused on TGFBI and NFKB2, based on their strong implication in ccRCC progression [25,29] and known regulation by VHL in the case of TGFBI [27,28]. The gene discussed is TGFBI; the disease is nonpapillary renal cell carcinoma.